Stocks股票 / Health Care / WST
WST US listed · USD美股 · 美元
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems.西氏医药服务公司是一家注射用药品包装和给药系统的设计商和制造商。
Price chart价格图表
Technicals技术面
daily bars日线数据 · 2026-07-21Earnings财务业绩
next report下次财报 2026-07-23Estimates being cut预期下调
Valuation估值
Expensive vs sector相对行业偏贵| Multiple指标 | WST | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率(历史) | 51.38x | 28.59 | |
| P/B市净率 | 7.99x | 3.44 | |
| P/S市销率 | 8.25x | 2.97 | |
| Earnings yield盈利收益率 | 1.95% | 2.72 | |
| FCF yield自由现金流收益率 | 1.85% | 4.00 | |
| Shareholder yield股东收益率 | 0.77% | 1.89 | |
| EV/EBITDA企业价值/EBITDA | 32.76x | 18.18 | |
| P/FCF市值/自由现金流 | 54.10x | 22.08 |
Financials财务数据
fiscal years财年Leverage杠杆
Capital allocation资本配置
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚Options positioning期权持仓
as of last close截至上一收盘Market makers are net long gamma — price pinned near current level做市商净持有正伽玛,价格倾向于在当前水平附近震荡
Flow:资金流向: $1M premium traded; 1% 0DTE; 2 fresh positions; P/C 0.18; ~leans bearish/hedging (direction approx)成交权利金 $1M;0DTE占1%;2个新建仓;看跌看涨比 0.18;≈偏看跌/对冲(方向近似)
Ownership & smart money持仓与聪明钱
13FConcentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| Viking Global (Halvorsen) | B | Adding加仓 | 0.3% | 2026-03-31 |
| Gates Foundation Trust | D | Holding持有 | 0.3% | 2026-03-31 |
Signal history信号历史
engine events引擎事件Company profile公司档案
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems.西氏医药服务公司是一家注射用药品包装和给药系统的设计商和制造商。
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率(静态) | 51.4× | 28.6× | 17% |
| Price / Book市净率 | 8.0× | 3.4× | 15% |
| Price / Sales市销率 | 8.2× | 3.0× | 15% |
| EV / EBITDAEV/EBITDA | 32.8× | 18.2× | 18% |
| Earnings yield盈利收益率 | 1.9% | 2.7% | 38% |
| Free-cash-flow yield自由现金流收益率 | 3.0% | 5.5% | 23% |
| Shareholder yield股东综合回报率 | 0.8% | 1.9% | 29% |
Relative strength相对强度
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | -2.1% | -0.9% |
| 1 Month近1月 | +7.4% | -0.6% |
| 3 Months近3月 | +28.3% | +5.4% |
| 6 Months近6月 | +38.3% | +8.6% |
| Year to date年初至今 | +27.7% | +8.9% |
| 1 Year近1年 | +67.6% | +19.2% |
Trading information交易信息
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $2.1B | $2.8B | $2.9B | $2.9B | $2.9B | $3.1B |
| EPS每股收益 | $4.57 | $8.67 | $7.73 | $7.88 | $6.69 | $6.79 |
| Free cash flow自由现金流 | $298M | $331M | $439M | $414M | $276M | $469M |
| Gross margin毛利率 | 35.8% | 41.5% | 39.4% | 38.3% | 34.5% | 35.9% |
| Net margin净利率 | 16.1% | 23.4% | 20.3% | 20.1% | 17.0% | 16.1% |
| FCF margin自由现金流利润率 | 13.9% | 11.7% | 15.2% | 14.1% | 9.6% | 15.3% |
Latest fiscal year最近财年
Returns & growth回报与增长
Accounting quality checks会计质量检查
- Earnings quality: accruals near the peer median盈利质量:应计利润接近同业中位
- Working capital: working capital roughly in line with sales营运资本:营运资本与销售大致同步
- Pricing power: gross margin +0.1pts over 6 years定价能力:毛利率 6 年上升 0.1 个百分点
- Capital discipline: investment near the peer median资本纪律:投资力度接近同业中位
- Balance sheet: Altman Z 16.89 — safe zone资产负债表:Altman Z 16.89——安全区
Indicator readings指标读数
Timeframe alignment多周期共振
Volatility regime波动状态
Estimate revisions预期修正
Dealer positioning map做市商持仓地图
Volatility pricing波动率定价
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| Viking Global (Halvorsen) | B | Adding增持 | 0.3% | $105M |
| Gates Foundation Trust | D | Holding持有 | 0.3% | $111M |